Novartis Aktie
99,06
EUR
+1,22
EUR
+1,25
%
92,15
CHF
+0,60
CHF
+0,66
%
Werbung
Novartis Aktie Analyse
05.06.24 | Novartis Buy | Deutsche Bank AG | |
03.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
03.06.24 | Novartis Buy | UBS AG | |
31.05.24 | Novartis Buy | UBS AG | |
31.05.24 | Novartis Buy | Jefferies & Company Inc. | |
30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
24.05.24 | Novartis Buy | Deutsche Bank AG | |
Werbung
|
|||
23.05.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
06.05.24 | Novartis Buy | UBS AG | |
26.04.24 | Novartis Buy | Jefferies & Company Inc. | |
24.04.24 | Novartis Buy | UBS AG | |
24.04.24 | Novartis Buy | Deutsche Bank AG | |
24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
23.04.24 | Novartis Underweight | Barclays Capital | |
23.04.24 | Novartis Buy | UBS AG | |
23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
18.04.24 | Novartis Buy | UBS AG | |
18.04.24 | Novartis Buy | Deutsche Bank AG | |
10.04.24 | Novartis Buy | UBS AG | |
04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
04.04.24 | Novartis Buy | UBS AG | |
03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
28.03.24 | Novartis Underweight | Barclays Capital | |
25.03.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.03.24 | Novartis Buy | Deutsche Bank AG | |
07.02.24 | Novartis Buy | Deutsche Bank AG | |
07.02.24 | Novartis Neutral | JP Morgan Chase & Co. | |
06.02.24 | Novartis Underweight | Barclays Capital | |
06.02.24 | Novartis Buy | UBS AG | |
05.02.24 | Novartis Buy | Jefferies & Company Inc. | |
02.02.24 | Novartis Buy | Deutsche Bank AG | |
31.01.24 | Novartis Kaufen | DZ BANK | |
31.01.24 | Novartis Buy | UBS AG | |
31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
30.01.24 | Novartis Buy | UBS AG | |
16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
15.01.24 | Novartis Buy | UBS AG | |
09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
08.01.24 | Novartis Neutral | UBS AG | |
05.01.24 | Novartis Buy | Deutsche Bank AG | |
03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
03.01.24 | Novartis Buy | Jefferies & Company Inc. | |
21.12.23 | Novartis Underweight | Barclays Capital | |
19.12.23 | Novartis Buy | Deutsche Bank AG | |
05.12.23 | Novartis Neutral | JP Morgan Chase & Co. | |
30.11.23 | Novartis Buy | Deutsche Bank AG | |
29.11.23 | Novartis Underweight | Barclays Capital |
Werbung
Werbung